secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-06-11T23:59:59+00:00
Accession:  0001683168-24-004120
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

All Series A Warrants exercised by holders as of June 11, 2024
--------------------------------------------------------------

- Series A Warrants issued on Feb 15, 2024 fully exercised as of June 11, 2024.
- No details on number of warrants, exercise price, or total proceeds provided.
- Exercise may result in dilution but share count impact not disclosed.
- Company did not specify use of proceeds from the warrant exercises.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004120/0001683168-24-004120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004120/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer